Clinical Trials Directory

Trials / Completed

CompletedNCT03791944

3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma

3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma - a Randomized, Single-blind, Multi-center Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Xinqiao Hospital of Chongqing · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Verify that 3DV+TPS is non-inferior compared to existing imported TPS and superior to existing domestic TPS.

Detailed description

The main purpose of the study was to verify that 3DV+TPS is non-inferior compared to existing imported TPS and superior to existing domestic TPS. A total of 100 patients were enrolled. The primary endpoint of the study was the objective response rate (ORR), and the secondary endpoint was the local control rate and the incidence of treatment-related side effects.

Conditions

Interventions

TypeNameDescription
DEVICE3DV+TPS/VARIANUse imported 3DV+TPS to map targets and develop treatment plans
DEVICETPS / VARIANUse imported TPS to map targets and develop treatment plans
DEVICE3DV + TPS / Domestic AcceleratorUse domestic 3DV+TPS to delineate target areas and develop treatment plans
DEVICETPS / Domestic AcceleratorUse domestic TPS to map targets and develop treatment plans

Timeline

Start date
2018-12-01
Primary completion
2019-01-31
Completion
2019-05-31
First posted
2019-01-03
Last updated
2024-02-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03791944. Inclusion in this directory is not an endorsement.